Dehydroevodiamine is a major bioactive quinazoline alkaloid isolated from Evodiae Fructus, has an antiarrhythmic effect in guinea-pig ventricular myocytes. Dehydroevodiamine inhibits LPS-induced iNOS, COX-2, prostaglandin E2 (PGE2) and nuclear factor-kappa B (NF-κB) expression in murine macrophage cells.
体外研究
Dehydroevodiamine (0-50 μM; 2 hours) inhibits iNOS and COX-2 expression and prevents degradation of IκB-α in LPS induced RAW 264.7 macrophages.
Dehydroevodiamine (0-50 μM; 2 hours) inhibits a LPS-induced increase in the iNOS and COX-2 mRNA expression.
Western Blot Analysis
Cell Line:
RAW 264.7 macrophage cells
Concentration:
10 μM, 30 μM, 50 μM
Incubation Time:
pretreated 2 hours
Result:
Reduced iNOS and COX-2 expression and increased IκB-α expression.
RT-PCR
Cell Line:
RAW 264.7 macrophage cells
Concentration:
10 μM, 30 μM, 50 μM
Incubation Time:
pretreated 2 hours
Result:
Reduced iNOS and COX-2 mRNA expression.
分子式
C19H15N3O
分子量
301.34
CAS号
67909-49-3
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.